Lexapro Launched in Japan Despite Birth Defect Risks
This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm. I always find it baffling that even in the face of overwhelming evidence that a drug causes severe side effects that far outweigh the benefits of treatment, drug companies can push through an approval process with the pressure and influence of
Read MoreDePuy ASR Hip Recall Problems Get Worse
Regular readers of this blog will remember that when the DePuy ASR Hip recall was first announced on August 24, 2010, I predicted that the problems that prompted the recall were understated and would only get worse. Well, I was unfortunately right. I have a lot of experience with defective hips. My experience in hip
Read MoreBirth Defects Linked to Increased Risk of Brain Tumors
The results of an intensive study conducted at Lucile Packard Children’s Hospital in Palo Alto, California revealed that children born with birth defects were nearly four times more likely to suffer from primitive neuroectodermal tumors compared to normal children. Because birth defects or fetal death during pregnancy often involves some type of genetic abnormality, that
Read MoreSSRI Stroke Risk
Hopefully, by now, everyone should be aware of the overwhelming evidence pointing to the association of drugs like Lexapro, Celexa, Zoloft, Prozac, and Paxil with birth defects. Now, however, there is a new wrinkle in the SSRI safety profile. Depressed middle-aged and older women are at significantly increased risk of stroke according to a new
Read MoreConsumer Alert! Dilfucan Birth Defect Warnings
This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm. Recent studies have indicated that Diflucan, the popular medication used to treat yeast infections, has been associated with birth defects including congenital heart defects and cleft palate. Diflucan joins a growing list of medications such as Lexapro, Celexa, Zoloft, Prozac, Paxil,
Read MoreMultaq Safety Concerns Over Cardiovascular Injury and Liver Failure
Maltaq was approved by the FDA in July 2009 for the treatment of abnormal heart rhythms. Soon after entering the market, disturbing reports of liver failure were reported with the drug. More recently, the FDA has warned of association with severe, even life threatening, cardiovascular problems. I encourage all my readers to discuss these new
Read MoreConsumer Alert! Fosamax Linked to Esphogeal Cancer
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Another serious safety concern with Fosamax! Can this drug get any worse in terms of a safety profile? Today FDA Communications issued a warning derived from a study from the UK General Practice Database that users of Fosamax of three years
Read MoreConsumer Alert! Transvaginal Mesh Warnings
This really big news concerning vaginal mesh dangers. Today, in an abrupt change from their position in October 2008, the FDA issued an update informing patients that serious complications associated with surgical mesh for transvaginal repair of POP are not rare. This is a change from what the FDA previously reported on October 20, 2008.
Read MoreMichael Brady Lynch Lectures at AAJ Annual Convention
Today, I was honored with the privilege of lecturing to over 150 attorneys at Litigation at Sunrise II at the American Association for Justice’s Annual Convention in New York City. It has been a great five days in New York. Although my lecture was very early in the morning, the attendance was great and the
Read MoreMichael Brady Lynch Appointed Chair of Nexium Litigation Group
Today was another busy day at the American Association for Justice’s Annual Convention in New York City. Of special note, I was honored with the appointment as Chair of the Nexium / Proton Pump Inhibitor Litigation Group. Proton Pump Inhibitors (PPI) like Nexium and Prilosec have been associated with severe bone breaks after long-term use
Read More